Literature DB >> 19484371

Parallel synthesis of a series of non-functional ATP/NAD analogs with activity against trypanosomatid parasites.

Andreas Link1, Philipp Heidler, Marcel Kaiser, Reto Brun.   

Abstract

Non-functional analogs of the cofactors ATP and NAD are putative inhibitors of ATP- or NAD-dependant enzymes. Since pathogenic protozoa rely heavily on the salvage of purine nucleosides from the bloodstream of their host, such compounds are of interest as antiplasmodial and antitrypanosomal agents with a multitude of molecular targets. By replacing the negatively charged phosphate residues with a constrained unsaturated amide spacer and the nicotinamide moiety of NAD with various lipophilic substituents, 15 new ATP/NAD analogs were obtained in screening quantities. In these compounds, a 5'-desoxyadenosine moiety was conserved as key molecular recognition motif. The inhibition of P. falciparum and T. brucei ssp. in a whole parasite in vitro assay is reported.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484371     DOI: 10.1007/s11030-009-9160-x

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  51 in total

1.  Comments on the Terminology for Applications of Temporarily Attached Solubility-Modifying Moieties in Combinatorial Chemistry.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-11-17       Impact factor: 15.336

2.  Impact of conformational flexibility on three-dimensional similarity searching using correlation vectors.

Authors:  Steffen Renner; Christof H Schwab; Johann Gasteiger; Gisbert Schneider
Journal:  J Chem Inf Model       Date:  2006 Nov-Dec       Impact factor: 4.956

3.  Ribose-modified purine nucleosides as ribonucleotide reductase inhibitors. Synthesis, antitumor activity, and molecular modeling of N6-substituted 3'-C-methyladenosine derivatives.

Authors:  Loredana Cappellacci; Palmarisa Franchetti; Patrizia Vita; Riccardo Petrelli; Antonio Lavecchia; Hiremagalur N Jayaram; Philipp Saiko; Geraldine Graser; Thomas Szekeres; Mario Grifantini
Journal:  J Med Chem       Date:  2008-06-28       Impact factor: 7.446

4.  Trypanosoma brucei: expression of multiple purine transporters prevents the development of allopurinol resistance.

Authors:  Manal J Natto; Lynsey J M Wallace; Denise Candlish; Mohammed I Al-Salabi; Shona E Coutts; Harry P de Koning
Journal:  Exp Parasitol       Date:  2005-01-08       Impact factor: 2.011

5.  Conformations of nicotinamide adenine dinucleotide (NAD(+)) in various environments.

Authors:  P E Smith; J J Tanner
Journal:  J Mol Recognit       Date:  2000 Jan-Feb       Impact factor: 2.137

6.  Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines.

Authors:  P Van de Vijver; G H M Vondenhoff; S Denivelle; J Rozenski; J Verhaegen; A Van Aerschot; P Herdewijn
Journal:  Bioorg Med Chem       Date:  2008-11-27       Impact factor: 3.641

7.  Transient species in the stepwise interconversion of NADH and NAD+.

Authors:  Jerzy Gebicki; Andrzej Marcinek; Jacek Zielonka
Journal:  Acc Chem Res       Date:  2004-06       Impact factor: 22.384

8.  Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.

Authors:  Karen M Grant; Morag H Dunion; Vanessa Yardley; Alexios-Leandros Skaltsounis; Doris Marko; Gerhard Eisenbrand; Simon L Croft; Laurent Meijer; Jeremy C Mottram
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  Preparation, biological activity and endogenous occurrence of N6-benzyladenosines.

Authors:  Karel Dolezal; Igor Popa; Eva Hauserová; Lukás Spíchal; Kuheli Chakrabarty; Ondrej Novák; Vladimír Krystof; Jirí Voller; Jan Holub; Miroslav Strnad
Journal:  Bioorg Med Chem       Date:  2007-03-16       Impact factor: 3.641

10.  Cordycepin (3'-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3beta activation and cyclin D1 suppression.

Authors:  Noriko Yoshikawa; Shizuo Yamada; Chihiro Takeuchi; Satomi Kagota; Kazumasa Shinozuka; Masaru Kunitomo; Kazuki Nakamura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.